• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration

    2021-12-17 03:15:56XinFnHowiZhnYnZhnxinChnXioonSun

    Xin Fn Ho wi Zhn Yn Zhn xin Chn Xioon Sun

    a Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China

    b Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China

    c Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China

    d National Clinical Research Center for Eye Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China

    e Ningbo Hygeia Medical Technology Co., Ltd., Ningbo 315201, China

    f School of Bioengineering, Dalian University of Technology, Dalian 116024, China

    g College of Pharmacy, Dalian Medical University, Dalian 116044, China

    Keywords: Age-related macular degeneration Anti-angiogenesis Gene therapy Polymer Vascular endothelial growth factor

    ABSTRACT In light of the intriguing potential of anti-angiogenic approach in suppressing choroidal neovascularization,we attempted to elaborate synthetic gene delivery systems encapsulating anti-angiogenic plasmid DNA as alternatives of clinical antibody-based therapeutics.Herein,block copolymer of cyclic Arg-Gly-Asp-poly(ethylene glycol)-poly(lysine-thiol) [RGD-PEG-PLys(thiol)]with multifunctional components was tailored in manufacture of core-shell DNA delivery nanoparticulates.Note that the polycationic PLys segments were electrostatically complexed with anionic plasmid DNA into nanoscaled core,and the tethered biocompatible PEG segments presented as the spatial shell (minimizing non-specific reactions in biological milieu).Furthermore,the aforementioned self-assembly was introduced with redox-responsive disulfide crosslinking due to the thiol coupling.Hence,reversible stabilities,namely stable in extracellular milieu but susceptible to disassemble for liberation of the DNA payloads in intracellular reducing microenvironment,were verified to facilitate transcellular gene transportation.In addition,RGD was installed onto the surface of the proposed self-assemblies with aim of targeted accumulation and internalization into angiogenic endothelial cells given that RGD receptors were specifically overexpressed on their cytomembrane surface.The proposed anti-angiogenic DNA therapeutics were validated to exert efficient expression of anti-angiogenic proteins in endothelial cells and elicit potent inhibition of ocular neovasculature post intravitreous administration.Hence,the present study approved the potential of gene therapy in treatment of choroidal neovascularization.In light of sustainable gene expression properties of DNA therapeutics,our proposed synthetic gene delivery system inspired prosperous potentials in long-term treatment of choroidal neovascularization,which should be emphasized to develop further towards clinical translations.

    1.Introduction

    Indulgence in electronic displays,owing to their high-energy visible light and ultraviolet,has prompted a rapidly growing population of choroidal neovascularization (CNV),which has been acknowledged to be a major cause of blindness across the world.In reference to the recent statistics,CNV comprises an estimated 2.5% of people aged over 40 years [1–3].Note that wet age-related macular degeneration (wAMD) was characterized by CNV,which provokes progressive leakage of blood and fluid,eventually leading to vision loss [4–6].In principle,CNV is stimulated by vascular endothelial growth factor (VEGF),diffusible cytokines that prompt angiogenesis and vascular permeability [7,8].Pertaining to the clinical therapeutic regime,intravitreal administration of VEGF antagonists (e.g.ranibizumab or bevacizumab) that specifically bind to the VEGF,have been verified to be a valid approach in suppressing CNV progression of wAMD and improving visual acuity [9–14].Nonetheless,the aforementioned antibody-based therapeutics are required to be repeatedly administered at 4–8 weeks interval,which not only conflicts the patient compliance but also increases the risks of ocular inflammation,retinal injury and endophthalmitis [15,16].To this drawback,gene therapy as alternative to antibody-based therapeutics is desirable in light of long-term protein expression of the encoded therapeutic gene in the affected cells [17,18].For instance,genomic therapeutics recently developed by our laboratory have demonstrated intriguingly consistent gene expression in cell spheroids over 90 days,and the levels of the expressed proteins were recorded to be appreciably constant [19].Hence,this tempting constant gene expression profile is postulated to not only allow reduced dosage frequencies (thus improved patient compliance) but also contribute to improved therapeutic outcomes in respect to the constant retention of high level of therapeutic proteins in the pathologic sites.

    However,to accomplish gene therapy,appropriate delivery systems are imperative to transport the inherently biologically fragile DNA to the cell interior (cell nucleus) for efficient gene expression since the supramolecular DNA owing to its large scale (micrometer) and intrinsic negative-charge forbids its diffusion across the lipophilic and negatively charged cytomembranes,not to mention the other biological barriers hindering the successful intracellular gene transportation [20,21].It should be noted for viral vectors,despite their tempting transfection efficiencies,whose fatal concerns (e.g.severe immunogenicity,limited gene-loading capacity and difficulties in industrial scale-up) motivate us to seek an alternative approach in manufacture of delivery vehicles for intracellular gene transportation [22,23].To the essential prerequisites for gene delivery,we intended to exploit materials-based molecular design in manufacture of non-viral synthetic gene delivery systems to accomplish gene therapy.

    In the present research,the negatively charged plasmid DNA was schemed to electrostatically complex with cationic block copolymers of poly(ethylene glycol)-polylysine (PEG-PLys).Consequently,the DNA condensates initialized by electrostatic complexation with the cationic PLys segments as the internal core,was postulated to be surrounded by the hydrophilic and biocompatible PEG shell.With the aim of adequate colloidal stability in the physiological environment,thiol groups were introduced into the side chains of PLys with the intention of crosslinking of the internal pDNA/PLys core by means of disulfide linkage between the thiols.Notably,the disulfide linkage was fairly stable in the extracellular milieu (relative oxidizing environments),thereby affording substantial stability to withstand the potential structural dissociation in the bloodstream or extracellular milieu.On the contrary,the disulfide bond is susceptible to cleavage in the intracellular compartments.Note that the intracellular milieu is characterized to be remarkably reducing compartments,intracellular structural disassembly from the proposed self-assemblies could be readily anticipated in subsequence to disulfide cleavage,which consequently facilitates the pDNA release from the aforementioned DNA self-assemblies for smooth gene expression machinery.On the other hand,targeting moieties of cyclic Arg-Gly-Asp (RGD) peptide were also installed onto the surface of the PEGylated self-assemblies.In view the specific affinities of RGD peptide to the angiogenic vasculatures (the receptors of RGD,including

    α

    β

    and

    α

    β

    integrins,are overexpressed on the angiogenic endothelial cells),hence preferential accumulation and thus efficient protein expression of therapeutic proteins (anti-VEGF) in CNV could be envisioned in the treatment of wAMD.

    2.Materials and methods

    2.1.Materials

    α

    -Methoxy-

    ω

    -amino-PEG (M w 12,000) and acetal-PEG-NH(M w 12,000) was purchased from SinoPEG Co.(Xiamen,China).N-Trifluoroacetyl-L-lysine N-carboxyanhydride [Lys(TFA)-NCA]was purchased from Hubei Jusheng Co.(Wuhan,China).Dithiothreitol (DTT),diethylenetriamine (DET),N,N-dimethylformamide (DMF),dichloromethane,benzene,and trifluoroacetic acid were purchased from Wako Pure Chemical Industries,Ltd.N-succinimidyl-3-(2-pyridyldithiol)propionate (SPDP) was purchased from Santa Cruz Biotechnology,Inc.(Santa Cruz,CA).Fetal bovine serum (FBS) was purchased from Dainippon Sumitomo Parma Co.,Ltd.(Osaka,Japan).Cell culture lysis buffer and luciferase Assay System Kit was purchased from Promega Co.(Madison,WI).Dulbecco’s modified Eagle’s medium (DMEM) was purchased from Sigma–Aldrich (St.Louis,MO).In pertinent to the cellular uptake and intracellular distribution assay,pDNA was labeled with Cy5 using a Label IT Nucleic Acid Labeling Kit from Mirus Bio Corporation (Madison,WI) according to the manufacturer’s protocol.For aqueous phase SEC,LC-2000 system (JASCO,Tokyo,Japan) equipped with Superdex200 10/300 GL (GE Healthcare,Tokyo,Japan) and a UV detector was used for characterizations.All animal experimental procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals as stated by the guidelines of Shanghai General Hospital (Shanghai Jiao Tong University School of Medicine).

    2.2.Polymer synthesis

    Block copolymer of PEG-PLys(thiol) and RGD-PEG-PLys(thiol) was synthesized based on ring opening polymerization.In brief,amine-functionalized Meo-PEG-NH 2 was employed as macroinitiator for polymerization of monomers of Lys(TFA)-NCA for block copolymeric PEG-PLys(TFA).The protective TFA groups was removed by hydrolysis reaction in NaOH.Furthermore,thiol groups were introduced into the side chain of the synthetic PLys segment in block copolymeric PEG-PLys based on its reaction with SPDP.The yielded PEG-PLys(SPDP) was transferred under treatment of DTT to obtain PEG-PLys(thiol).On the other hand,acetal-PEG-NHwas employed for synthesis of acetal-PEG-PLys(thiol) by following the similar synthetic route,which was transferred for acidic treatment to yield aldehyde-PEG-PLys(thiol).Cysteine-functionalized cyclic RGD was attempted for reaction with aldehyde group of aldehyde-PEG-PLys(thiol) to obtain the ultimate RGD-PEG-PLys(thiol).The detailed synthetic procedures were described in Supporting Information.

    2.3.Dynamic light scattering (DLS)

    The hydrodynamic diameters of the formulated pDNA delivery systems were measured by DLS (Zetasizer nanoseries,Malvern Instruments Ltd.,Worchestershire,UK).All DLS measurements were conducted independently for at least three times at 25 °C.Note that the rate of decay in the photon correlation function was analyzed by referring to a cumulant method.Accordingly,the yielded hydrodynamic diameters were concluded based on the Stokes-Einstein equation.

    2.4.Cellular uptake

    Human umbilical vein endothelial cells (HUVECs) were seeded onto 6-well culture plates (50 000 cells/well) in cell culture medium (2 ml) containing 10% FBS and 1% antibiotics (penicillin and streptomycin) and incubated in a humidified atmosphere supplemented with 5% CO 2 at 37 °C.After 24 h incubation,the medium was replaced with fresh medium.The cells were treated by addition of PEG-PLys/pDNA,PEG-PLys(thiol)/pDNA and RDG-PEG-PLys(thiol)/pDNA (1 μg of Cy5-labeled pDNA/well) and followed by another 24 h incubation.The medium was discarded,and the cells were washed three times with ice-cold PBS to remove extracellular fluorescence.Furthermore,the cells were subjected to trypsin-EDTA treatment,and the trypsinized cells were harvested and resuspended in 1 ml ice-cold PBS.the cell suspension was filtered through a nylon mesh and transferred for analysis by a BDLSR II flow cytometer equipped with FACS-Divasoftware (BD Biosciences,Franklin Lakes,NJ) to quantify the intracellular pDNA quantity.Note that the cellular uptake efficiencies were expressed as the mean fluorescence intensities from Cy5-pDNA based on three independent samples (

    n

    =3).

    2.5.Gene expression efficiency

    HUVECs were seeded onto 24-well culture plates (20 000 cells/well) in 400 μl cell culture medium containing 10% FBS and 1% antibiotics (penicillin and streptomycin) and incubated in a humidified atmosphere supplemented with 5% CO 2 at 37 °C.At 24 h post incubation,gene delivery systems containing the reporter pDNA od CAG-Luc were added to each well for 48 h incubation.Note that fresh medium was replaced at 24 h interval.At 48 h post transfection,the cells were washed three times with 400 μl ice-cold PBS and lysed in 150 μl cell lysis buffer at 37 °C for 10 min.Furthermore,20 μl of the cell lysate was transferred into a 96-well luminometry plate,followed by addition of 100 μl of Luciferase Assay Reagent (Promega,Madison,WI),and allowed for 15 min reaction.The expressed Luc protein was quantified for 10 s recording of the photoluminescence intensities by Mithras LB 940 (Berthold Technologies,Bad Wildbad,Germany).Meanwhile,the quantities of the total protein in the cell lysate was quantified according to the classical Micro BCAProtein Assay Kit (Pierce,Rockford,IL).The obtained Luc activities was normalized against the corresponding quantities of the total protein in the cell lysates.Herein,the gene expression levels were expressed as relative light units (RLU) per mg of protein (RLU/mg protein) (

    n

    =4).

    2.6.Animals

    C57BL/6 mice (approximate 7 weeks,20 g) were used in anti-CNV study.Note that all the animal experiments were conducted strictly according to the guidelines of the ARVO statement for the Use of Animals in Ophthalmic and Vision Research.The experimental protocols were approved by Institutional Animal Care and Use Committee of Shanghai Jiao Tong University (Shanghai,China).The mice were housed and subjected to containment in the animal care services facility with 12 h light/dark cycle and constant access to nourishments.

    2.7.Laser-induced CNV

    CNV was established according to our previously reported protocol.In brief,pupil dilatation was performed with tropicamide (Santen,Osaka,Japan),followed by anesthetization based on intraperitoneal injection of 1% pentobarbital sodium (0.1 ml/10 g body weight,Guge Biotech,Wuhan,China) into C57BL/6 mice.To proceed photoagulation,loxacin eye ointment (Xing Qi Pharmaceutical Companies,Shenyang,China) was placed on top of corneal,and four laser spots were located at the vicinities of the optic nerve head with an argon laser (110 mW,100 ms,50 μm,OcuLight Infrared Laser System 810 nm,Iridex Corp.,Mountain View,CA,USA).Appearance of a gray bubble indicative of the rupture of Bruch’s membrane were included.If retinal bleeding occurred,the animal was eliminated.Eyes were enucleated at different time points.

    2.8.Intravitreal injection

    Synthetic gene delivery systems containing sFlt-1 were intravitreal administered into the vitreous cavity using fine,32-G needles and 10 μl syringes (cat.No 80,330;both form Hamilton,Reno,NV).Note that the injection process was carefully conducted with the aids of microscope through the flattened cornea (covered with ointment),and the tip of the needle is required to penetrate the sclera,choroid,and retina to reach the vitreous cavity.An approximate volume of 2 μl per injection was applied to each eye.

    2.9.Fluorescence angiography

    FA imaging was conducted on day 7 post photocoagulation to assess the severity of CNV leakage.Prior to FA imaging,mice were subjected to sequential intraperitoneal dosage of 1% sodium pentobarbital (Guge Biotech,Wuhan,China) for anesthetization at 5 μl/g body weight and 10% fluorescein sodium (0.5 ml,Fluorescite,Alcon,Tokyo,Japan) for bio-imaging.Fundus angiogram photos were captured at the middle stage (2–3 min post injection of fluorescein sodium) using a digital fundus camera (Heidelberg Retina Angiograph,Vista,CA).Furthermore,the relative fluorescence intensity of each CNV lesion was quantified with the aids of ImageJ platform (National Institutes of Health,Bethesda,MD).The average intensity of each CNV lesion with leakage was calculated according to our previously reported protocol (Burgess et al.,2010).In brief,an outline was drawn to encompass each CNV area,and mean fluorescence was measured,along with three adjacent background readings.The total corrected CNV fluorescence (TCCF)=integrated density– (area of selected area ×mean fluorescence of background readings),was calculated.This TCCF was equalized against the mean TCCF of retina vessels,with results presented as fold increase over interphase levels.We defined the intensity of retinal vessels as one and the avascular area as zero and the signal intensity for each pixel was represented from zero (darkest) to one (brightest).

    2.10.Perfusion fixation

    Immunofluorescence procedures require perfusion fixation to stabilize the proteins or peptides in the choroid in order to allow for subsequent antibody binding to the antigenic site on those proteins or peptides.At end points of Day 7 after laser and sFlt-1 treatment,mice were perfused transcardially with cold 4% paraformaldehyde using a previously described protocol with minor modifications (Gerfen,2003).In brief,mice were administered with an over dose (0.2 ml) of 1% sodium pentobarbital and monitored until the point when the animal fails to respond to pinching of the foot.Incisions in the abdomen and diaphragm were made to expose the heart and perfusion needle was placed into ascending aorta.Cold 4% paraformaldehyde was poured into left ventricle of mouse through a peristaltic perfusion pump (Cole-Parmer Masterflex,NY).Twitching of muscles suggests that the perfusion is proceeding properly.After the effluent runs clear,pump was stopped,eyes and spleens were harvested,post-fixed for 2 h and then placed in PBS to make choroidal flatmounts or put into 30% sucrose solutions to make frozen sections.

    2.11.Choroidal flatmount and immunofluorescence staining

    Choroidal flatmounts were performed under an operating microscope (Olympus,Tokyo,Japan) subsequent to perfusion fixation and post-fixation.In brief,the cornea,lens and vitreous were removed from the harvested eye.The retina was carefully dissected from the choroid.Furthermore,six radial incisions were applied to the remaining RPE-choroid cup for flattened choroid,which is immediately transferred for immunostaining treatment.Prior to immunostaining,the RPE-choroid complexes were blocked in 5% goat serum albumin (containing 0.3% Triton X-100) for 1 h at room temperature,followed by incubation with FITC-labeled isolectin-B4 (IB4) (FL-1201,Vector Laboratories,Burlingame,CA) at 4 °C.After overnight reaction,the RPE-choroid complexes were rinsed and transferred for incubation with Alexa Fluor 488-labelled secondary antibodies (SA00003-11,Proteintech,Chicago,MI) for 1 h at room temperature.Eventually,fluorescence images were conducted under a fluorescence microscope (Olympus,Tokyo,Japan) or a confocal laser scanning microscope (CLSM) (Leica TCS SP8,Leica TCS NT,Wetzlar,Germany).

    2.12.Statistical analysis

    The

    P

    values were determined based on the Student’s

    t

    -test using a two-tailed distribution and two-sample un-equal variance with the

    T

    .Test function of Microsoft Excel.The

    P

    values less than 0.05 were considered as statistically significant.

    3.Results and discussion

    3.1.Synthesis of block copolymeric RGD-PEG-PLys(thiol) and chemical characterizations

    Fig.1–Synthetic route in synthesis of block copolymeric RGD-PEG-PLys(thiol).

    The block copolymer of RGD-PEG-PLys(thiol) was synthesized according to Fig.1 .In brief,acetal-PEG-NH 2 was employed as the macro-initiator for ring-opening polymerization of the monomers of Lys(TFA)-NCA for production of acetal-PEG-PLys(TFA).Furthermore,the protecting TFA residues in the units of PLys(TFA) segment were removed under treatment in NaOH (0.1 N) to yield cationic bloc copolymer of acetal-PEG-PLys.Furthermore,the amino groups of lysine in acetal-PEG-PLys were used for conjugation of SPDP,followed by DTT treatment to yield the thiol groups.Ultimately,acetal-PEG-PLys(thiol) was incubated in acidic condition for transformation of the terminus acetal groups into aldehyde groups,which was schemed to react with cysteine groups from RGD to yield the ultimate block copolymer of RGD-PEG-PLys(thiol).The resulting copolymeric RGD-PEG-PLys(thiol),as well as the control copolymers of PEG-PLys,were characterized by bothH NMR and C-NMR measurements (Figs.S1–S5).As shown in Fig.S5,the polymerization degree of PLys segment was determined to be approximate 60.4,and the percentage of thiol substitution was estimated to be approximate 14.6% in relative to the total lysine units.Moreover,successful conjugation of cyclic RGD to the block copolymer was verified due to the evident peaks at 7.2–7.3 ppm,assignable to the protons from the phenyl groups of RGD,and the conjugation efficiency was estimated to exceed 97.2% per block copolymer.GPC measurement for the ultimate RGD-PEG-PLys(thiol) copolymer verified appreciable unimodal molecular weight distribution (Fig.S6).

    3.2.Fabrication of gene delivery systems based on electrostatic self-assembly and physiochemical characterizations

    The yielded functional block copolymer of RGD-PEG-PLys(thiol) was used to complex with polyanionic pDNA under gentle vortex,followed by 5 min incubation and sequential dialysis against DMSO-containing aqueous solution (DMSO:10 mM) and distilled water for disulfide crosslinking.Note that the positively charged PLys segments could electrostatically assemble with the negatively charged plasmid DNA (pDNA) into polyionic complex core,and the non-ionic hydrophilic PEG segments would surround the formed PLys/pDNA complex core as the external shells (Fig.2 A).The resulting formation of RGD-PEG-PLys(thiol)/pDNA was characterized by DLS.As shown in Fig.2 B,nanoscaled formation possessing approximate 61.2 nm in hydrodynamic diameter was confirmed with unimodal size distribution (PDI:0.09),which is contrast to the larger scale of naked pDNA (approximate 700 nm in hydrodynamic diameter by DLS measurement),suggesting the electrostatic condensation of pDNA by polycationic RGD-PEG-PLys(thiol) into favorable sub-100 nm nanoscale structures.Meanwhile,neutralization of the negative charges of pDNA (?38.4 mV) was also verified post complexation with RGD-PEG-PLys(thiol),as evidenced by the appreciable+2.4 mV for RGD-PEG-PLys(thiol)/pDNA.This appreciable neutral surface charge verified the excellent charge-masking function from PEG surface modification,which is critical in reducing electrostatic reactions in the complicated biological environment.Charge neutralization of pDNA was also confirmed by gel electrophoresis study for pDNA upon complexation with RGD-PEG-PLys(thiol)/pDNA at varied

    N

    /

    P

    ratios (defined as the molar ratio of the amine groups from block polymer to the phosphate groups from pDNA).As shown in Fig.S7,complete complexation of pDNA was identified at

    N

    /

    P

    ratios exceeding stochiometric charge ratio (

    N

    /

    P

    ≥ 1).Furthermore,the morphologies of pDNA condensates were characterized by TEM measurement.As shown in Fig.2 C,distinctive nanoscaled rod-like structures were observed,whose average length was measured to be approximate 100 nm.This distinctive rod-shape condensate is not surprising with respect that double-strand DNA (dsDNA) is rigid macromolecule,whose persistence length is approximate 50 nm in physiological condition.Consequently,the condensation of pDNA would follow a regular folding scheme into DNA bundles rather than collapse into spherical structures [24–26].Of note,the obtained rod-shaped nanostructures were reported to exert appreciable high cellular uptake activities,as well as high gene expression activities due to the facilitated transcription by means of the regular DNA folding scheme [26].

    Fig.2–Schematic illustration and physiochemical characterizations of synthetic gene delivery system from RGD-PEG-PLys(thiol).(A) Illustration in manufacture of multifunctional genomic nanoconstructs from self-assembly of RGD-PEG-PLys(thiol) and pDNA;(B) DLS (C):TEM for insight on the morphologies of RGD-PEG-PLys(thiol)/pDNA.Scale bar:100 nm.

    Fig.3–Insight on structural dissociation of pDNA self-assemblies from PEG-PLys and PEG-PLys(thiol) under incubation with polyanionic heparin at varied concentrations (units:mg/ml).

    3.3.Reversible stabilities of gene delivery systems due to redox crosslinking

    Aiming for adequate colloidal stabilities in the physiological environment,the aforementioned self-assemblies were introduced with redox-responsive crosslinking so as to withstand the potential exchange reactions and thus prevent the premature dissociation in the harsh physiological environment.As shown in gel electrophoresis (Fig.3),ready structural dissociation and thus liberation of the pDNA payloads was confirmed for PEG-PLys/pDNA self-assemblies (void of disulfide crosslinking) in presence of bio-existing polyanionic glycosaminoglycan (heparin:1.0 mg/ml).In contrast,the colloidal stabilities were observed to be substantially improved for PEG-PLys(thiol)/pDNA self-assemblies as evidenced by negligible pDNA liberation despite their incubation in presence of polyanionic heparin at a concentration of 5.0 mg/ml (Fig.3).This observation approved the functional role of disulfide crosslinking in strengthening colloidal stabilities of electrostatically-based self-assemblies in the biological milieu.Aside from adequate colloidal stabilities in the extracellular milieu,the proposed RGD-PEG-PLys(thiol)/pDNA self-assemblies is also designed to be capable of readily liberating the pDNA payloads in the cell interiors so as to facilitate the subsequent transcription and translation machinery.Given that the cell interior is characterized to be a significantly reducing compartment that commits to elimination of the detrimental reactive oxygen species,for instance,abundant reducing substances of glutathione (GSH) have documented in the cytosol (in the range of several 10–100 mM),yet the extracellular level of GSH was estimated to be in the range of serval 10–100 μM [27,28].Therefore,the redox-responsive disulfide linkage in the constructed nanocolloidals is envisioned to be selectively cleavable in the cytosol,while the disulfide crosslinking is fairly stable in extracellular milieu (including extracellular matrix and bloodstream).Consequently,the electrostatically-assembled nanocolloidals lack of chemical crosslinking are susceptible to exchange reactions with polyanionic species in view of diverse anionic polyanions existing in the intracellular compartment (e.g.nucleic acids) and on the cytoplasm structures (e.g.glycosaminoglycans),leadingly facilitating pDNA release for subsequent DNA transcription and translation machinery.In consistent with our speculation,readily pDNA release was confirmed for RGD-PEG-PLys(thiol)/pDNA self-assemblies in presence of GSH (50 mM,mimicking the intracellular milieu),comparable to PEG-PLys/pDNA.To this end,the facile redox-responsive stabilities were confirmed for the proposed RGD-PEG-PLys(thiol)/pDNA self-assemblies,which afford adequate colloidal stabilities in the extracellular environment but readily dissociation and release of pDNA payloads in the targeted cell interiors,thereby beneficial in accomplishing promoted gene expression in the targeted cells.

    3.4.Promoted cellular uptake and transfection due to disulfide crosslinking and surface RGD modification

    Fig.4–In vitro performance of a class of synthetic gene delivery systems upon incubation in HUVECs.(A) cellular uptake efficiencies,scale bar:20 μm;(B) gene expression efficiencies,scale bar:100 μm.

    Fig.5–Transgene expression of Gaussia luciferase after transfection to HUVEC spheroids using synthetic gene delivery system from RGD-PEG-PLys(thiol).

    Herein,the cellular uptake and gene expression efficiencies were evaluated in HUVECs.Note that HUVECs are angiogenic endothelial cells that widely used as the model cells representative for vascular endothelial cells.To start up,the cellular uptake efficiencies of a class of polyplex micelles,including PEG-PLys/pDNA,PEG-PLys(thiol)/pDNA and RGD-PEG-PLys(thiol)/pDNA,were evaluated in HUVECs by flow cytometry and CLSM measurements (Fig.4 A).Overall,cell uptake appeared for all the polyplex micelles,implying the importance of fabrication of nanoscaled DNA condensates in pursuit of cell internalization.In details,limited cellular uptake efficiency was confirmed for PEG-PLys/pDNA (Fig.4 A).Especially,no additional cell uptake was observed for PEG-PLys/pDNA after 4 h transfection (Fig.4 A),which should be as a result of its poor colloidal stabilities in the biological milieu.Presumably,PEG-PLys/pDNA was susceptible to structural dissociation in the extracellular conditions,and structural disassembly occurred within the initial 4 h incubation (Fig.3).Namely,minimal nanoscaled self-assemblies remain after 4 h incubation,therefore very limited cellular uptake efficiency could be expected despite extended incubation.On the contrary,consistent cellular uptake was observed for PEG-PLys(thiol)/pDNA,suggesting the validity of our disulfide strategy in enhancing colloidal stabilities to seek improved cellular uptake efficiency.To our interests,RGD-PEG-PLys(thiol) mediated highest level of cellular uptake (Fig.4 A).A plausible reason for this appreciable cellular uptake efficiency from RGD-PEG-PLys(thiol)/pDNA should be attributable to the specific affinity of RGD and its receptors which are overexpressed across a number of angiogenic cells (including HUVECs),consequently specific interactions between RGD ligand and receptors affording favorable cellular endocytosis activities into the angiogenic HUVECs.In consistent with cellular uptake results,the gene expression efficiency appeared to follow a similar trend (Fig.4 B),wherein the pDNA construct from RGD-PEG-PLys(thiol) presented highest transfection efficiency,markedly higher than the self-assemblies from PEG-PLys(thiol) and PEG-PLys.Hence,the self-assemblies from RGD-PEG-PLys(thiol) was ultimately employed for encapsulation of anti-VEGF gene for treatment of CNV.It is also should be noted that long-term gene expression was confirmed from our proposed genomic therapeutic (Fig.5).The proposed genomic construct encapsulating soluble Gaussia luciferase (Gluc)-encoding pDNA was attempted for transfection with HUVEC-based spheroids,and the extracellular expression of Gluc was quantified up to 32 d post transfection.As shown in Fig.5,consistent gene expression was observed,and no significant decline was confirmed despite extended incubation.This long-term gene expression profile is apparently favorable to the ultimate therapeutic outcomes,namely the therapeutic proteins from our proposed gene therapeutic strategy were believed to conduce to potent and enduring anti-angiogenic microenvironment to suppress the pathogenesis.

    3.5.Remarkable in vivo expression of anti-angiogenic proteins and potent suppression on CNV

    With the aim of suppressing CNV,an anti-VEGF gene (plasmid DNA) encoding soluble fms-related tyrosine kinase 1 (sFlt-1),was attempted as the genomic payloads for construction of gene delivery systems.In view that VEGF plays a fundamental role in promoting neovascularization and edema in wAMD,disruption of VEGF signaling should serve as a rational approach to interfere the progression of CNV.Herein,CNV were induced according to our previously established laser photocoagulation protocol.At 24 h post photocoagulation,CNV was confirmed by fluorescence angiography.To explore the therapeutic efficacy of our constructed anti-VEGF gene delivery systems,varied dosages of RGD-PEG-PLys(thiol)-based self-assemblies containing anti-VEGF pDNA (sFlt-1) was administered

    via

    intravitreous injection.The expression levels of the therapeutic payloads of sFlt-1 pDNA were evaluated in CNV regions by ELISA at 48 h post dosage.As shown in Fig.6 A,markedly sFlt-1 expression was confirmed from our proposed gene delivery systems from RGD-PEG-PLys(thiol),which is envisioned to endow anti-VEGF microenvironment in suppressing angiogenesis.Herein,the therapeutic efficacy was assessed by fluorescence angiography on Day 7 post treatment.As shown in Fig.6 B,aggressive neovasculature was observed for the control PBS group.On the contrary,the commercial VEGF antibody of Conbercept appeared to exert potent inhibition on progression of neovascularization,as evidenced by reduced angiogenic blood vessels.Noteworthy is the efficacy of our proposed gene delivery systems containing sFlt-1,which exhibited significant suppression in the growth of neovasculature (Fig.6 B).Close examination identified the suppression activities followed distinct dosage-dependent manner,and significant eradiation of neovasculature was achieved at dosage of 0.8 μg sFlt-1 pDNA.Furthermore,aiming for quantitatively estimation of the therapeutic efficacies,the vascular densities of the CNV lesions were quantified by calculating the positive areas of choroidal blood vessels post choroidal flatmount and immunostaining.Significant lowered CNV areas were confirmed for the sample of RGD-PEG-PLys(thiol)/sFlt-1 (Fig.7).It should be noted that,there was no significant difference between the PBS control group RGD-PEG-PLys(thiol)/Luc (containing non-therapeutic Luc gene),suggesting the obtained therapeutic efficacies as a result of expression of the loaded anti-angiogenic sFlt-1.Presumably,RGD-PEG-PLys(thiol)/sFlt-1 due to its specific affinity to the angiogenic endothelial cells,could preferentially accumulate in the blood vessels.Furthermore,the proposed redox-responsive motif of the proposed RGD-PEG-PLys(thiol)/sFlt-1 self-assembly allowed efficient gene expression in the targeted endothelial cells.The expressed sFlt-1,once secreted from the cells,manage to diffuse around and readily trap the angiogenic VEGF cytokines,ultimately contributing to inhibited neovasculature.Noteworthy is the therapeutic efficacy of our proposed gene delivery systems based on single dosage comparable to the most potent antibody-based therapeutics (Conbercept),validating its clinical potential in treatment of wAMD.Hence,the prosperous potential of anti-angiogenic strategy in treatment of wAMD was verified based on intravitreous injection of gene delivery systems encapsulating sFlt-1 gene.Aside from the therapeutic efficacy,appreciable safety profile was also confirmed for our constructed gene delivery systems,as evidenced by their excellent biocompatibilities.As shown in Fig.S8,negligible cytotoxicity was confirmed for the self-assemblies of RGD-PEG-PLys(thiol)/pDNA,meanwhile,minimal hemolysis was also verified when RGD-PEG-PLys(thiol)/pDNA was incubated with defibrinated sheep red blood cells.At 6 h post incubation,the hemolysis rates of RBCs were verified to be rather negligible (merely 2% even at a high concentration up to 0.2 mg/ml,Fig.S9),in stark contrast to the hemolysis rates of RBCs under incubation with amphiphiles of Tween80 to be 20.1% and 72.8% at the concentration of 0.25 and 1 mg/ml).Together with appreciable therapeutic efficacies,our proposed anti-angiogenic gene delivery system of RGD-PEG-PLys(thiol)/pDNA illustrates an intriguing tool for clinical persistent inhibition of CNV.

    Fig.6–Therapeutic assessment on our proposed anti-angiogenic therapeutics composed of RGD-PEG-PLys(thiol).(A) Quantification of the expressed sFlt-1 by ELISA.(B) Insight into the CNV leakage by ocular fluorescence angiography on Day 7 post treatment of synthetic gene delivery system from RGD-PEG-PLys(thiol) (< 1 ×> assigned to be 0.1 μg sFlt-1 pDNA).Note that intraperitoneal administration of fluorescein sodium was schemed prior to observation,scale bar:200 μm.

    Fig.7–Evaluation on choroidal vascular densities upon diverse treatment.(A) the choroidal flatmount images to illustrate neovasculatures,scale bar:100 μm;(B) the quantified densities of neovasculature were summarized into bar graph.

    4.Conclusions

    The rising population suffering from CNV encouraged tremendous efforts in development of potent therapeutics to tackle with this global leading cause for irreversible blindness.To manage this formidable disease,we are motivated to construct anti-angiogenic genomic therapeutics to verify the feasibility of gene therapy in treatment of CNV.In the present study,synthetic gene delivery system was rationally tailored with multifunctional motifs,including active targeting function to the angiogenic endothelial cells,stimuli-responsive stabilities to release the DNA payloads selectively in the cell interiors,which consequently contributed to efficient gene expression at the targeted cells.Note that the constructed delivery system encapsulating anti-angiogenic gene was determined to accomplish potent CNV suppression.Therefore,our proposed gene delivery system implied tremendous potential of gene therapy as an alternative approach for treatment of CNV.Considering the versatile genomic tools available in gene therapy,for instance,Crispr/Cas gene editing or RNA interference,our proposed gene delivery system could be further exploited to find broad utilities in achieving appropriate therapeutic consequences in treatment of intractable ocular diseases.

    Conflicts of interest

    The authors declare no competing financial interest.

    Acknowledgments

    This research was funded by National Natural Science Foundation of China (81900869,81730026,81802482),National Key R&D Program (2019YFC0840607,2017YFA0105301),Science and Technology Commission of Shanghai Municipality (17411953000,19495800700),Shanghai Sailing Program (19YF1439500),Talent Project of Revitalizing Liaoning (XLYC1807184),and Dalian Science&Technology Innovation Fund (2020JJ26SN050).

    Supplementary materials

    Supplementary material associated with this article can be found,in the online version,at doi:10.1016/j.ajps.2021.04.001 .

    一区二区三区四区激情视频| 久久精品国产亚洲av天美| 天天影视国产精品| 99视频精品全部免费 在线| 国产精品偷伦视频观看了| 黑人高潮一二区| 好男人视频免费观看在线| 晚上一个人看的免费电影| 亚洲精品一二三| 国产永久视频网站| a级毛片免费高清观看在线播放| 国产在视频线精品| 一级爰片在线观看| 国产男女超爽视频在线观看| 久久久久久久久久成人| 大片免费播放器 马上看| 综合色丁香网| 伦理电影免费视频| 2018国产大陆天天弄谢| 夫妻午夜视频| 国产精品女同一区二区软件| 亚洲色图综合在线观看| 日韩免费高清中文字幕av| 久久久久精品性色| 在线观看www视频免费| 亚洲图色成人| 久久精品国产鲁丝片午夜精品| 日韩精品免费视频一区二区三区 | 大片免费播放器 马上看| 最近手机中文字幕大全| 天天影视国产精品| 精品人妻偷拍中文字幕| 成人影院久久| 香蕉精品网在线| 国产精品99久久久久久久久| 日本av免费视频播放| 多毛熟女@视频| 欧美日韩av久久| 日韩电影二区| 这个男人来自地球电影免费观看 | 日韩,欧美,国产一区二区三区| 日本与韩国留学比较| 亚洲欧洲精品一区二区精品久久久 | 青春草国产在线视频| av视频免费观看在线观看| 男的添女的下面高潮视频| 在线观看三级黄色| 国产精品99久久99久久久不卡 | 观看美女的网站| 热re99久久精品国产66热6| av专区在线播放| 满18在线观看网站| 丰满乱子伦码专区| 久久久精品区二区三区| 国产成人精品福利久久| 女人精品久久久久毛片| 美女国产高潮福利片在线看| 国产又色又爽无遮挡免| 亚洲色图 男人天堂 中文字幕 | 国产免费一区二区三区四区乱码| 老女人水多毛片| 十八禁网站网址无遮挡| 亚洲欧洲国产日韩| 热99国产精品久久久久久7| 99久久人妻综合| 日韩精品免费视频一区二区三区 | 久久国产精品男人的天堂亚洲 | 各种免费的搞黄视频| 日韩免费高清中文字幕av| 国产色爽女视频免费观看| 天堂中文最新版在线下载| 亚洲精品色激情综合| 99久久精品国产国产毛片| 又黄又爽又刺激的免费视频.| 插逼视频在线观看| 国产成人精品婷婷| 韩国av在线不卡| 91精品一卡2卡3卡4卡| 亚洲精品久久久久久婷婷小说| 国产高清国产精品国产三级| 久久久精品区二区三区| 亚洲成人av在线免费| 亚洲怡红院男人天堂| av卡一久久| 精品人妻一区二区三区麻豆| 高清黄色对白视频在线免费看| 亚洲经典国产精华液单| 久久鲁丝午夜福利片| 亚洲欧美一区二区三区国产| 国产视频内射| 成年人免费黄色播放视频| 2022亚洲国产成人精品| 久久午夜综合久久蜜桃| 内地一区二区视频在线| 国产男女超爽视频在线观看| 免费不卡的大黄色大毛片视频在线观看| 亚洲四区av| 亚洲三级黄色毛片| 欧美日韩在线观看h| 国产黄片视频在线免费观看| 国产乱人偷精品视频| 肉色欧美久久久久久久蜜桃| 精品久久蜜臀av无| 建设人人有责人人尽责人人享有的| 亚洲无线观看免费| 极品人妻少妇av视频| 亚洲欧美清纯卡通| kizo精华| 免费观看a级毛片全部| 免费观看无遮挡的男女| 一级爰片在线观看| 街头女战士在线观看网站| 精品少妇久久久久久888优播| 99热这里只有精品一区| av.在线天堂| 有码 亚洲区| 亚洲欧美日韩另类电影网站| 91精品三级在线观看| 久久精品久久久久久噜噜老黄| 成人无遮挡网站| 亚洲国产毛片av蜜桃av| 91aial.com中文字幕在线观看| 日本av手机在线免费观看| 成年av动漫网址| 你懂的网址亚洲精品在线观看| 777米奇影视久久| 亚洲人与动物交配视频| 久久久久久久久久久免费av| 国国产精品蜜臀av免费| 亚洲人成网站在线播| 成人亚洲欧美一区二区av| 97超视频在线观看视频| 精品人妻熟女av久视频| 久久av网站| 99热国产这里只有精品6| 日韩欧美精品免费久久| 免费看不卡的av| 午夜av观看不卡| 久久午夜福利片| 日韩视频在线欧美| 欧美日韩精品成人综合77777| 男男h啪啪无遮挡| 久久久a久久爽久久v久久| 母亲3免费完整高清在线观看 | 久久国产精品大桥未久av| 亚州av有码| 狂野欧美激情性bbbbbb| 国产白丝娇喘喷水9色精品| 一本—道久久a久久精品蜜桃钙片| 成年人午夜在线观看视频| 日日摸夜夜添夜夜添av毛片| 亚洲欧美成人综合另类久久久| 2021少妇久久久久久久久久久| 一区二区日韩欧美中文字幕 | 色婷婷av一区二区三区视频| 狂野欧美激情性bbbbbb| 欧美日韩综合久久久久久| 国产男女内射视频| 久热久热在线精品观看| 国产成人精品无人区| 美女xxoo啪啪120秒动态图| 中文字幕免费在线视频6| 久久人妻熟女aⅴ| 成人影院久久| 丝袜喷水一区| 91国产中文字幕| 久久韩国三级中文字幕| 精品一区二区三卡| 又大又黄又爽视频免费| 成年人午夜在线观看视频| 国产毛片在线视频| 18禁裸乳无遮挡动漫免费视频| 国产精品99久久99久久久不卡 | 中文字幕精品免费在线观看视频 | 欧美日韩成人在线一区二区| 亚洲国产最新在线播放| 人人妻人人爽人人添夜夜欢视频| 色吧在线观看| 晚上一个人看的免费电影| 日本免费在线观看一区| av天堂久久9| 99热这里只有精品一区| a级毛片在线看网站| 亚洲精品久久午夜乱码| 80岁老熟妇乱子伦牲交| 亚洲av.av天堂| 欧美xxxx性猛交bbbb| 不卡视频在线观看欧美| 亚洲国产欧美在线一区| 如何舔出高潮| 纵有疾风起免费观看全集完整版| 亚洲色图综合在线观看| 另类亚洲欧美激情| 免费不卡的大黄色大毛片视频在线观看| 亚洲精品成人av观看孕妇| 五月开心婷婷网| 国产男人的电影天堂91| 妹子高潮喷水视频| 国产有黄有色有爽视频| xxxhd国产人妻xxx| av视频免费观看在线观看| 最新中文字幕久久久久| 建设人人有责人人尽责人人享有的| 久久女婷五月综合色啪小说| 国产精品女同一区二区软件| 在线观看免费视频网站a站| 3wmmmm亚洲av在线观看| 少妇 在线观看| 亚洲av二区三区四区| 精品久久国产蜜桃| 国产亚洲精品第一综合不卡 | 观看美女的网站| 亚洲国产毛片av蜜桃av| 又大又黄又爽视频免费| 久久久精品区二区三区| 伊人亚洲综合成人网| 高清不卡的av网站| 日韩在线高清观看一区二区三区| 亚洲av福利一区| 美女视频免费永久观看网站| 亚洲av日韩在线播放| 一区二区三区四区激情视频| 欧美老熟妇乱子伦牲交| 免费久久久久久久精品成人欧美视频 | 最近手机中文字幕大全| 五月开心婷婷网| 黑人猛操日本美女一级片| av线在线观看网站| 日韩亚洲欧美综合| 午夜精品国产一区二区电影| 亚洲精品一二三| 超色免费av| 黑人猛操日本美女一级片| 精品国产国语对白av| 熟妇人妻不卡中文字幕| 中国美白少妇内射xxxbb| 伊人亚洲综合成人网| 精品久久久久久久久av| 老司机亚洲免费影院| 国产精品麻豆人妻色哟哟久久| 久久国产精品大桥未久av| 国产成人91sexporn| 丝袜美足系列| 丁香六月天网| 免费观看av网站的网址| 午夜激情久久久久久久| 国产乱来视频区| 在线天堂最新版资源| 9色porny在线观看| av视频免费观看在线观看| www.色视频.com| 久久久精品区二区三区| 亚洲精品亚洲一区二区| 日韩亚洲欧美综合| 国产av码专区亚洲av| 视频中文字幕在线观看| 亚洲精华国产精华液的使用体验| 有码 亚洲区| 伊人久久国产一区二区| 精品国产乱码久久久久久小说| 国产 精品1| 99精国产麻豆久久婷婷| 91精品伊人久久大香线蕉| kizo精华| 久久久精品94久久精品| 一个人免费看片子| 少妇人妻久久综合中文| 久久久久久久国产电影| 日本色播在线视频| 日韩一区二区三区影片| 日韩人妻高清精品专区| 亚洲精品日本国产第一区| 日韩熟女老妇一区二区性免费视频| 亚洲精品国产色婷婷电影| 亚洲国产毛片av蜜桃av| 日韩不卡一区二区三区视频在线| 嘟嘟电影网在线观看| av网站免费在线观看视频| 一区二区三区免费毛片| 国产白丝娇喘喷水9色精品| 久久午夜综合久久蜜桃| 久久这里有精品视频免费| 亚洲av.av天堂| 如何舔出高潮| 午夜av观看不卡| 欧美xxxx性猛交bbbb| 国产精品久久久久久久电影| 国模一区二区三区四区视频| 色94色欧美一区二区| 在线观看美女被高潮喷水网站| 精品人妻在线不人妻| 亚洲综合色惰| 内地一区二区视频在线| 亚洲色图 男人天堂 中文字幕 | 老司机影院成人| 亚洲三级黄色毛片| 国产爽快片一区二区三区| 在线精品无人区一区二区三| 日韩不卡一区二区三区视频在线| 在线观看免费高清a一片| 久久久久久久国产电影| 久久久久久久久久久免费av| 久久久久久伊人网av| 美女国产高潮福利片在线看| 国产成人午夜福利电影在线观看| 如日韩欧美国产精品一区二区三区 | 成人国语在线视频| 丝袜脚勾引网站| 亚洲性久久影院| 亚洲美女视频黄频| 婷婷色综合www| 久热这里只有精品99| 国产黄频视频在线观看| 嫩草影院入口| 亚洲精品久久成人aⅴ小说 | 啦啦啦视频在线资源免费观看| kizo精华| 青春草亚洲视频在线观看| 亚洲丝袜综合中文字幕| 久久久国产一区二区| 免费黄频网站在线观看国产| 我的女老师完整版在线观看| 国产乱人偷精品视频| 26uuu在线亚洲综合色| 久久精品久久久久久久性| 日韩av在线免费看完整版不卡| 老司机亚洲免费影院| 美女脱内裤让男人舔精品视频| 少妇猛男粗大的猛烈进出视频| 亚洲久久久国产精品| 日韩强制内射视频| a级片在线免费高清观看视频| 2018国产大陆天天弄谢| 亚洲丝袜综合中文字幕| 国产亚洲午夜精品一区二区久久| 成人午夜精彩视频在线观看| 欧美国产精品一级二级三级| 少妇被粗大的猛进出69影院 | 校园人妻丝袜中文字幕| 国产成人freesex在线| 丰满迷人的少妇在线观看| 考比视频在线观看| 成人影院久久| 国产毛片在线视频| 天美传媒精品一区二区| 91精品三级在线观看| 久久人人爽av亚洲精品天堂| 国产毛片在线视频| 制服人妻中文乱码| a级片在线免费高清观看视频| 一级毛片电影观看| 赤兔流量卡办理| 夫妻午夜视频| 97超碰精品成人国产| 91久久精品国产一区二区三区| 精品一品国产午夜福利视频| 欧美少妇被猛烈插入视频| av专区在线播放| 午夜久久久在线观看| 大又大粗又爽又黄少妇毛片口| 精品久久蜜臀av无| 一级毛片aaaaaa免费看小| 啦啦啦在线观看免费高清www| 欧美精品高潮呻吟av久久| 亚洲一级一片aⅴ在线观看| 极品少妇高潮喷水抽搐| 亚州av有码| 国产精品麻豆人妻色哟哟久久| 成人国语在线视频| 精品一区二区三卡| 久久久精品94久久精品| a级片在线免费高清观看视频| 日韩强制内射视频| 97超碰精品成人国产| 久久午夜综合久久蜜桃| 99国产精品免费福利视频| 国产成人av激情在线播放 | √禁漫天堂资源中文www| 欧美97在线视频| 又粗又硬又长又爽又黄的视频| 国产日韩欧美在线精品| 多毛熟女@视频| av视频免费观看在线观看| 免费av中文字幕在线| 赤兔流量卡办理| 国产精品一区二区在线不卡| 久久精品国产亚洲av涩爱| 国产黄片视频在线免费观看| 伦理电影大哥的女人| 热re99久久国产66热| 久久久久久久久久人人人人人人| 午夜福利影视在线免费观看| 国产成人精品无人区| 下体分泌物呈黄色| 永久免费av网站大全| 精品少妇黑人巨大在线播放| 亚洲天堂av无毛| 成人无遮挡网站| 80岁老熟妇乱子伦牲交| 又大又黄又爽视频免费| 久久精品国产亚洲网站| 日韩一本色道免费dvd| 丝袜脚勾引网站| 男女边摸边吃奶| 三级国产精品片| 欧美日韩在线观看h| 欧美 日韩 精品 国产| 26uuu在线亚洲综合色| 丝瓜视频免费看黄片| 亚洲国产av影院在线观看| 97在线人人人人妻| 亚洲综合色网址| 久久狼人影院| 国产精品一区二区在线不卡| 亚洲精品美女久久av网站| 少妇猛男粗大的猛烈进出视频| 九草在线视频观看| 好男人视频免费观看在线| 九九在线视频观看精品| 亚洲欧美中文字幕日韩二区| av在线观看视频网站免费| 国产精品久久久久久精品古装| 少妇被粗大猛烈的视频| 日日啪夜夜爽| 一边亲一边摸免费视频| 亚洲精华国产精华液的使用体验| 在线观看美女被高潮喷水网站| 岛国毛片在线播放| 亚洲精品国产av成人精品| 成人毛片60女人毛片免费| 在线免费观看不下载黄p国产| 2022亚洲国产成人精品| 亚洲精品国产av蜜桃| 国产伦精品一区二区三区视频9| 极品少妇高潮喷水抽搐| 一级a做视频免费观看| 欧美激情 高清一区二区三区| 久久久久久久精品精品| 精品国产一区二区三区久久久樱花| 一本一本综合久久| 欧美亚洲 丝袜 人妻 在线| 如何舔出高潮| 一本—道久久a久久精品蜜桃钙片| 美女中出高潮动态图| 国产片内射在线| 国产探花极品一区二区| 一区二区三区乱码不卡18| 久久99一区二区三区| 97精品久久久久久久久久精品| 制服诱惑二区| 新久久久久国产一级毛片| 欧美精品国产亚洲| 97超碰精品成人国产| 国产高清有码在线观看视频| 老熟女久久久| 色婷婷av一区二区三区视频| h视频一区二区三区| 9色porny在线观看| 免费av不卡在线播放| 五月天丁香电影| 日产精品乱码卡一卡2卡三| 纯流量卡能插随身wifi吗| av免费在线看不卡| 亚洲人成网站在线观看播放| 国产黄片视频在线免费观看| 国产精品久久久久久久电影| 少妇人妻精品综合一区二区| 少妇丰满av| 精品亚洲成国产av| √禁漫天堂资源中文www| 国产精品99久久久久久久久| 丰满少妇做爰视频| a级毛片在线看网站| 999精品在线视频| 久久久久久久久大av| 秋霞伦理黄片| 亚洲欧美日韩卡通动漫| 天堂中文最新版在线下载| 亚洲五月色婷婷综合| av免费观看日本| 国产亚洲av片在线观看秒播厂| 亚洲欧洲日产国产| 久久鲁丝午夜福利片| 丰满少妇做爰视频| 午夜日本视频在线| 亚洲精品乱码久久久v下载方式| 啦啦啦在线观看免费高清www| 亚洲无线观看免费| 丰满少妇做爰视频| 国产黄色免费在线视频| 久久精品国产亚洲av天美| 日韩av免费高清视频| 久久久久久久久久成人| 一本久久精品| 欧美日韩成人在线一区二区| 伊人久久国产一区二区| 91久久精品国产一区二区三区| 精品酒店卫生间| 久久国内精品自在自线图片| 久久99蜜桃精品久久| 日日啪夜夜爽| 国产高清国产精品国产三级| 亚洲人成77777在线视频| 熟女人妻精品中文字幕| av免费观看日本| 国产精品麻豆人妻色哟哟久久| 青春草亚洲视频在线观看| 亚洲av二区三区四区| 黄色视频在线播放观看不卡| 日韩中字成人| 日韩电影二区| 日日摸夜夜添夜夜爱| 在线看a的网站| 亚洲精品中文字幕在线视频| 一本—道久久a久久精品蜜桃钙片| 97超碰精品成人国产| 好男人视频免费观看在线| 久久久亚洲精品成人影院| 久久久久久人妻| 国产亚洲午夜精品一区二区久久| 伦理电影大哥的女人| 久久久久精品性色| 久久精品久久久久久噜噜老黄| 成人综合一区亚洲| av在线播放精品| 高清黄色对白视频在线免费看| 欧美亚洲日本最大视频资源| 亚洲国产欧美在线一区| 国产成人freesex在线| 在现免费观看毛片| 婷婷色综合大香蕉| 日韩电影二区| 少妇猛男粗大的猛烈进出视频| 亚洲av欧美aⅴ国产| 久久久久久久国产电影| 多毛熟女@视频| 亚洲经典国产精华液单| 亚洲精品第二区| 日本vs欧美在线观看视频| 国产精品人妻久久久久久| 国产免费一区二区三区四区乱码| 2022亚洲国产成人精品| 国产亚洲av片在线观看秒播厂| 成人漫画全彩无遮挡| 一级毛片黄色毛片免费观看视频| 国产69精品久久久久777片| 亚洲精品乱久久久久久| 精品人妻熟女毛片av久久网站| 国产精品嫩草影院av在线观看| 哪个播放器可以免费观看大片| 国产成人精品一,二区| 国产黄片视频在线免费观看| 纵有疾风起免费观看全集完整版| 18禁观看日本| 91久久精品国产一区二区三区| 成人亚洲欧美一区二区av| 一边摸一边做爽爽视频免费| 日韩大片免费观看网站| 久久精品国产亚洲av涩爱| 女性被躁到高潮视频| 日本午夜av视频| 日韩精品免费视频一区二区三区 | 观看美女的网站| 亚洲av日韩在线播放| 亚洲av不卡在线观看| 国产亚洲午夜精品一区二区久久| 国产精品一区二区在线观看99| 99热全是精品| 亚洲精品乱久久久久久| 欧美日本中文国产一区发布| 黄色视频在线播放观看不卡| 精品久久久久久电影网| 亚洲国产精品999| 日本欧美国产在线视频| 精品国产乱码久久久久久小说| 精品人妻在线不人妻| 欧美日韩国产mv在线观看视频| av在线观看视频网站免费| 午夜影院在线不卡| 一二三四中文在线观看免费高清| 亚洲av中文av极速乱| 久久久国产欧美日韩av| 人人妻人人添人人爽欧美一区卜| 男女免费视频国产| 内地一区二区视频在线| 中国国产av一级| 国产免费福利视频在线观看| 国产欧美日韩一区二区三区在线 | 黄色一级大片看看| 熟女人妻精品中文字幕| 久久久久久久久大av| 精品人妻熟女毛片av久久网站| 欧美日韩av久久| 色婷婷av一区二区三区视频| 99国产精品免费福利视频| 国产 精品1| 亚洲综合色惰| 伊人久久精品亚洲午夜| 99久久精品国产国产毛片| 亚洲一区二区三区欧美精品| 久久久久久久大尺度免费视频| 国产国拍精品亚洲av在线观看| 人人妻人人澡人人爽人人夜夜| 久久久久精品性色| 亚洲熟女精品中文字幕| 在线观看人妻少妇| 国产黄片视频在线免费观看| 91午夜精品亚洲一区二区三区| 老女人水多毛片| 免费观看无遮挡的男女| 欧美日韩成人在线一区二区| 亚洲三级黄色毛片| 成人无遮挡网站| 日本午夜av视频| 免费看不卡的av|